+86-13627358501
01
Non-Animal Derived Injection Grade Hyaluronic Acid
Product specification
| Brand Name | MHW CHEM |
| Model Number | MHW-FU-2025014 |
| Product Name | Hyaluronic acid |
| Chemical Formula | (C14H21NO11)n |
| Chemical Structure |
|
| CAS No. | 9004-61-9 |
| Appearance | White, fine powder |
| Assay | 95.0%~105.0% |
| Application | Medical aesthetic injectable products |
| Function | Tissue support, lubrication and hydration |
| Solubility | Soluble in water |
| Heavy metals | ≤10ppm |
| Protein | ≤0.1% |
| Bacterial endotoxins | ≤0.05IU/mg |
| Source | Microbial fermentation |
| Packaging | 100g/foil bag, 1kg/foil bag or as per customer’s request. |
| Shelf life | 2 years |
| Storage conditions | Avoid light, refrigerate 2℃~10℃, seal container. |
Features
Non-animal Derivative: Produced using fermentation technology, avoiding potential allergy and pathogen risks associated with animal-derived components.
Stable and Controllable Structure: Intact molecular chains and uniform molecular weight distribution help maintain physicochemical stability during injection.
Good Biocompatibility: High compatibility with human tissues, resulting in good post-injection tolerance.
Excellent Hydration and Support Capacity: Forms a stable hydration structure in vivo, providing continuous lubrication and buffering.
Compatible with Multiple Formulation Systems: Exhibits good dispersibility and compatibility in various solution systems.
Advantages
· The production process complies with injection-grade quality management standards, and key process nodes are controllable.
· Multiple refining and filtration processes effectively reduce protein residues, endotoxins, and impurities.
· High batch consistency and stable physicochemical indicators facilitate large-scale formulation production.
· A comprehensive testing system supports excellent quality traceability.
Applications
· Basic functional raw materials in medical aesthetic injectable products.
· Intra-articular injection lubricants and adjuvant therapy formulations.
· Development of ophthalmic-related injectable formulations.
· Other injectable medical products with high requirements for raw material sourcing and safety levels.





